Issue 1 | 16 February 2021
Study Overview The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.
Meet the Investigators
Progress Updates
Timeline
Available now... Background and Rationale video available now; https://www.tracktrial.org/background-and-rationale/